ZELLI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 727
EU - Europa 372
AS - Asia 17
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 1.119
Nazione #
US - Stati Uniti d'America 725
IE - Irlanda 235
IT - Italia 51
DE - Germania 23
SE - Svezia 23
FI - Finlandia 8
BE - Belgio 7
CN - Cina 6
GB - Regno Unito 6
VN - Vietnam 6
BG - Bulgaria 4
UA - Ucraina 4
ES - Italia 2
PL - Polonia 2
AU - Australia 1
BN - Brunei Darussalam 1
BR - Brasile 1
CA - Canada 1
DZ - Algeria 1
FR - Francia 1
HK - Hong Kong 1
IM - Isola di Man 1
IN - India 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MX - Messico 1
NO - Norvegia 1
RO - Romania 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.119
Città #
Chandler 233
Dublin 233
Jacksonville 60
New York 44
Ashburn 36
L’Aquila 32
Princeton 29
Lawrence 28
Wilmington 21
Bremen 20
Des Moines 20
Los Angeles 20
San Mateo 19
Fremont 9
Helsinki 8
Ann Arbor 7
Boardman 7
Brussels 7
Woodbridge 7
Dong Ket 6
Norwalk 5
Edinburgh 4
Sofia 4
Stockholm 4
Washington 4
Cedar Knolls 3
Beijing 2
Chicago 2
Ferentino 2
Redwood City 2
Sora 2
Warsaw 2
West Jordan 2
Algiers 1
Bandar Seri Begawan 1
Birmingham 1
Bratislava 1
Central 1
Cormeilles-en-Parisis 1
Douglas 1
Fairfield 1
Formia 1
Frosinone 1
Hanover 1
Il-Madliena 1
L'aquila 1
Lanciano 1
London 1
Macao 1
Madrid 1
Menlo Park 1
Miami 1
Oslo 1
Podgorica 1
Pune 1
Rome 1
San Giovanni Teatino 1
San Jose 1
Seattle 1
Shenzhen 1
Singapore 1
São Paulo 1
Tappahannock 1
Teramo 1
Totale 915
Nome #
Emerging role of isomirs in cancer: State of the art and recent advances 49
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 47
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 46
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 41
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 40
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 40
Methylome profiling of BRCA-positive and BRCA-negative MBCs 40
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 39
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 38
CD44 mRNA expression in hormonally treated and non-treated prostate cancer cases 38
Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers 38
The antiquity of hydrocephalus: the first full palaeo-neuropathological description 37
MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas 37
Metastases risk in thin cutaneous melanoma: Prognostic value of clinical-pathologic characteristics and mutation profile 36
Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy 36
449: Gene-specific methylation profiles in male breast cancer 36
Contribution of MUTYH variants to male breast cancer risk: results from a multicenter study in Italy 35
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy 35
Proffered papers and posters presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer— BRCA: Challenges and Opportunities 34
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 33
EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations 33
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 32
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene 31
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 31
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 30
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 29
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores 28
Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy 26
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in Italy 26
Transcriptome of male breast cancer matched with germline profiling reveals novel molecular subtypes with possible clinical relevance 26
PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report 24
Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers 21
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 19
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 18
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 12
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 7
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 4
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 3
Totale 1.175
Categoria #
all - tutte 6.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.185


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 2 0 3 0 0 3
2020/2021128 1 2 3 3 15 0 5 1 47 0 42 9
2021/2022143 0 4 0 1 24 1 5 8 13 3 9 75
2022/2023685 38 52 18 76 48 81 3 39 281 3 37 9
2023/2024211 19 9 21 7 13 79 1 37 2 18 5 0
Totale 1.175